PLX

Conviction 73HealthcareScan · Fri, Aug 7, 2026

PLX$2.45+0.41%

ResistanceSupportVol 14

Vol MA14 575.04K

May 8May 27Jun 15Jul 2Jul 22Aug 7

Protalix BioTherapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.protalix.com ↗

Price2.45

Change+0.41%

Gap+0.00%

Rel volume1.29×

Avg volume586.54K

Avg $ vol1.39M

SMA 202.36

SMA 502.24

SMA 2002.22

Price vs 50+9.25%

Price vs 200+10.41%

MA stackbullish

50/200 crossgolden · 4d

Supertrendup · 2.17

RSI (14)61

MACD hist0.00

MACD crossbull · 0d

Stoch %K / %D89 / 87

ADX (14)20

+DI / −DI27 / 13

RSI divergence—

MACD divergence—

ATR %+3.86%

ADR %4.08%

52w high3.15

52w low1.48

From 52w high-22.22%

Above 52w low+65.54%

New 52w highNo

SqueezeOn · 13d

Bollinger width8.57%

%B0.93

Donchian pos89.29%

Donchian high2.48

Donchian low2.20

AVWAP (52w high)2.32

vs AVWAP high+5.44%

AVWAP (52w low)2.25

vs AVWAP low+9.04%

OBV trendFlat

Chaikin MF (20)-0.05

Today vs 20d1.29×

Avg vol (14d)575.04K

Avg vol (20d)586.54K

Avg $ vol (20d)1.39M

Market cap197.4M

RS 3m (vs SPY)+16.06%

RS 6m (vs SPY)-27.87%

RS line new highNo

Trend template7/8

Technical rank53.2

1 week+3.38%

1 month+3.38%

3 months+23.74%

6 months-15.81%

1 year+65.54%

YTD+40.80%

P/E-29.89

P/B2.94

P/S3.74

P/FCF-14.48

EPS-0.0800

Div yield—

ROE-9.82%

ROA-6.45%

Debt/Eq0.01

Current3.15

EV/EBITDA—

Gross margin7.60%

Net margin-12.52%

Rev growth-1.23%

EPS growth-325.24%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value157.31M

Revenue33.75M

Net income18.32M

Gross profit-1.25M

Free cash flow-13.63M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNYSE

Shares out80.57M

Employees226

ListedTue, Jan 2, 1996

Free float71.57M

Float %89.0%

Short interest3.72M

Days to cover6.6d

Short volume55.4%

Squeeze score50 / 100

Next earningsWed, Aug 12, 2026 · pre-mkt (5d)

EPS forecast−$0.01 · 2 est

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction73 / 100

Pattern quality—

Tech rank53.2 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.47

Support2.10

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 45 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Broke out
Jun 24 – Jun 30
5 scans
→
Setting up
Jul 23 – Jul 27
2 scans

Congress activity

Disclosed STOCK Act trades in PLX

All disclosures →

No recent disclosed trades by Congress in PLX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PLX

No recent insider (Form 4) filings in PLX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in PLX · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.